rs377022215

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting

The NM_001040108.2(MLH3):​c.3539G>A​(p.Arg1180His) variant causes a missense change. The variant allele was found at a frequency of 0.0000942 in 1,571,810 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1180G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000042 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000099 ( 0 hom. )

Consequence

MLH3
NM_001040108.2 missense

Scores

3
10
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 6.17

Publications

1 publications found
Variant links:
Genes affected
MLH3 (HGNC:7128): (mutL homolog 3) This gene is a member of the MutL-homolog (MLH) family of DNA mismatch repair (MMR) genes. MLH genes are implicated in maintaining genomic integrity during DNA replication and after meiotic recombination. The protein encoded by this gene functions as a heterodimer with other family members. Somatic mutations in this gene frequently occur in tumors exhibiting microsatellite instability, and germline mutations have been linked to hereditary nonpolyposis colorectal cancer type 7 (HNPCC7). Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008]
MLH3 Gene-Disease associations (from GenCC):
  • colorectal cancer, hereditary nonpolyposis, type 7
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000995 (142/1427442) while in subpopulation MID AF = 0.000176 (1/5672). AF 95% confidence interval is 0.0000949. There are 0 homozygotes in GnomAdExome4. There are 67 alleles in the male GnomAdExome4 subpopulation. Median coverage is 27. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MLH3NM_001040108.2 linkc.3539G>A p.Arg1180His missense_variant Exon 5 of 13 ENST00000355774.7 NP_001035197.1 Q9UHC1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MLH3ENST00000355774.7 linkc.3539G>A p.Arg1180His missense_variant Exon 5 of 13 5 NM_001040108.2 ENSP00000348020.2 Q9UHC1-1

Frequencies

GnomAD3 genomes
AF:
0.0000416
AC:
6
AN:
144368
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0000514
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000732
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000448
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000124
AC:
31
AN:
250732
AF XY:
0.0000885
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.0000871
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000176
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.0000995
AC:
142
AN:
1427442
Hom.:
0
Cov.:
27
AF XY:
0.0000942
AC XY:
67
AN XY:
711234
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32518
American (AMR)
AF:
0.000114
AC:
5
AN:
43774
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25248
East Asian (EAS)
AF:
0.0000275
AC:
1
AN:
36414
South Asian (SAS)
AF:
0.000105
AC:
9
AN:
85634
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51250
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5672
European-Non Finnish (NFE)
AF:
0.000111
AC:
121
AN:
1088494
Other (OTH)
AF:
0.0000856
AC:
5
AN:
58438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000416
AC:
6
AN:
144368
Hom.:
0
Cov.:
27
AF XY:
0.0000431
AC XY:
3
AN XY:
69620
show subpopulations
African (AFR)
AF:
0.0000514
AC:
2
AN:
38890
American (AMR)
AF:
0.0000732
AC:
1
AN:
13652
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4730
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4618
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8970
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000448
AC:
3
AN:
66926
Other (OTH)
AF:
0.00
AC:
0
AN:
1966
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000113
Hom.:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.0000906
AC:
11

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:2
Sep 18, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R1180H variant (also known as c.3539G>A), located in coding exon 4 of the MLH3 gene, results from a G to A substitution at nucleotide position 3539. The arginine at codon 1180 is replaced by histidine, an amino acid with highly similar properties. This alteration was identified in the heterozygous state in a cohort of pancreatic cancer patients undergoing multigene panel testing (Young EL et al. BMC Cancer, 2018 Jun;18:697). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Colorectal cancer, hereditary nonpolyposis, type 7 Uncertain:1
May 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1180 of the MLH3 protein (p.Arg1180His). This variant is present in population databases (rs377022215, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MLH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 478037). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Colorectal cancer;C0476089:Endometrial carcinoma;C1858380:Colorectal cancer, hereditary nonpolyposis, type 7 Uncertain:1
Mar 30, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MLH3-related disorder Uncertain:1
Dec 08, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The MLH3 c.3539G>A variant is predicted to result in the amino acid substitution p.Arg1180His. This variant has been reported in an individual with a personal history of pancreatic cancer (Supplemental Table 2, Young et al. 2018. PubMed ID: 29945567). This variant is reported in 0.017% of alleles in individuals of European (Non-Finnish) descent in gnomAD. In ClinVar, it has been reported as a variant of uncertain significance by multiple laboratories (https://www.ncbi.nlm.nih.gov/clinvar/variation/478037/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.012
T
BayesDel_noAF
Uncertain
0.020
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.44
T;.;T
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.97
D;D;.
M_CAP
Benign
0.057
D
MetaRNN
Uncertain
0.62
D;D;D
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.2
M;M;M
PhyloP100
6.2
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-3.1
D;.;D
REVEL
Uncertain
0.50
Sift
Benign
0.045
D;.;D
Sift4G
Uncertain
0.0030
D;D;D
Polyphen
0.99
D;D;D
Vest4
0.58
MVP
0.91
MPC
0.57
ClinPred
0.34
T
GERP RS
5.8
Varity_R
0.25
gMVP
0.63
Mutation Taster
=44/56
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377022215; hg19: chr14-75506645; API